Ledercort Rx

Mometasone furoate, the active ingredient in Ledercort Rx, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal allergic rhinitis and nasal polyps in adults and children.

GNH USA supplies Ledercort Rx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ledercort Rx is a nasal corticosteroid that reduces inflammation in the upper airway. It is indicated for the following conditions:

Allergic rhinitis: reduces nasal congestion, itching and sneezing caused by perennial allergens. Seasonal allergic rhinitis: provides symptom relief during pollen or mold seasons. Nasal polyps: helps shrink polyps and improve nasal airflow.

Adverse reactions may occur with any nasal corticosteroid. Most are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Cough - Altered taste perception

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use - Cataracts or glaucoma - Severe allergic reaction (anaphylaxis) - Opportunistic fungal infection of the nasal mucosa - Vision changes - Persistent nasal septum perforation

Before using Ledercort Rx, consider the following safety points:

Pregnancy: consult a healthcare provider; safety data are limited. Breastfeeding: discuss potential risks with a physician. Pediatric use: follow prescriber guidance for age‑appropriate dosing. Concurrent nasal surgery: avoid use immediately before or after procedures. Do not exceed the prescribed dose. Store at room temperature: keep in the original packaging, protect from moisture and heat.

Mometasone furoate may interact with other medicines that affect corticosteroid activity or metabolism.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles: may increase mometasone levels. - Ritonavir or other protease inhibitors: may elevate exposure. - Nasal decongestants: may increase local irritation when used together.